V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250002493 | 250004625 | 1.77 | 55.6 | Palliative (P) | 2018-09-17 | 2019-05-03 | CARBOPLATIN + ETOPOSIDE | 02 | N | IPILIMUMAB + NIVOLUMAB | 100390503 |
| 250002495 | 250004627 | 0 | 58.8 | Neo-adjuvant (N) | null | 2019-12-06 | CARBOPLATIN | 2 | N | IMATINIB | 101263192 |
| 250002498 | 250004629 | 1.73 | 73 | null | null | 2020-11-04 | CABOZANTINIB | 02 | N | TRIAL UNSPECIFIED | 101816101 |
| 250002502 | 250004633 | null | null | Curative (C) | null | 2020-01-10 | CARBOPLATIN + VINORELBINE | null | null | CAPECITABINE + IRINOTECAN | 100633098 |
| 250002503 | 250004634 | 1.66 | 73.2 | Palliative (P) | 2018-12-14 | 2019-01-16 | Doxorubicin 75mg/m2 | 02 | Y | DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | 101081853 |
| 250002506 | 250004636 | null | null | Neo-adjuvant (N) | 2018-09-28 | 2018-10-19 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | DOXORUBICIN | 100352838 |
| 250002507 | 250004637 | 1.72 | null | Palliative (P) | null | 2020-05-14 | CARBOPLATIN + RT | 02 | N | ATEZOLIZUMAB | 100110559 |
| 250002511 | 250004640 | 0 | 74.6 | Curative (C) | null | 2017-04-26 | Trabectedin | 02 | null | DABRAFENIB + TRAMETINIB | 101394687 |
| 250002516 | 250004644 | 1.62 | 75.45 | null | null | 2020-03-17 | null | N | N | CARBOPLATIN | 100028319 |
| 250002518 | 250004646 | 1.94 | 64.5 | Palliative (P) | 2016-04-15 | 2016-08-01 | null | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100113525 |
| 250002519 | 250004647 | 1.74 | 88.3 | Curative (C) | null | 2019-12-29 | Trial Unspecified | 02 | N | CISPLATIN | 100586466 |
| 250002522 | 250004648 | null | null | Palliative (P) | 2021-04-28 | 2021-04-29 | null | 02 | null | DOXORUBICIN | 101018822 |
| 250002524 | 250004649 | null | null | null | 2018-10-28 | 2020-04-12 | Sunitinib | null | N | CAPECITABINE + OXALIPLATIN | 101406783 |
| 250002525 | 250004650 | 1.6 | 83.3 | Adjuvant (A) | 2019-04-22 | 2019-09-26 | IVADo | 02 | Y | IMATINIB | 100606801 |
| 250002531 | 250004656 | 1.88 | 78.2 | Neo-adjuvant (N) | null | 2020-04-23 | PACLITAXEL | 02 | Y | CARBOPLATIN + PEMETREXED | 100477388 |
| 250002532 | 250004657 | 1.79 | 84 | null | null | 2018-02-16 | REGORAFENIB | 02 | null | IMATINIB | 100605437 |
| 250000084 | 250004670 | 1.83 | 70.8 | null | 2018-04-19 | 2018-04-19 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | CARBOPLATIN + PEMETREXED | 100334374 |
| 250000106 | 250004671 | null | null | Adjuvant (A) | null | 2019-04-12 | null | null | N | CISPLATIN + FLUOROURACIL | 101580077 |
| 250000180 | 250004672 | null | 55 | Palliative (P) | 2020-06-17 | 2020-06-30 | Cisplatin | Y | null | CARBOPLATIN + ETOPOSIDE | 101019647 |
| 250000218 | 250004673 | null | null | Palliative (P) | null | 2017-07-31 | EW EuroEwing 2012 Arm B IE | null | N | TIVOZANIB | 101444568 |
| 250000331 | 250004677 | null | null | 03 | 2018-04-30 | 2018-05-24 | Cetuximab + CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101320011 |
| 250000391 | 250004678 | 1.8 | 61.3 | null | 2019-10-19 | 2019-11-16 | null | 02 | N | CARBOPLATIN + PACLITAXEL | 100808955 |
| 250000410 | 250004679 | null | null | null | 2019-11-04 | 2019-11-04 | null | 02 | null | IPILIMUMAB + NIVOLUMAB | 101474441 |
| 250000424 | 250004680 | 1.84 | 69 | Palliative (P) | 2016-06-14 | 2016-06-20 | null | 02 | null | CETUXIMAB | 101781180 |
| 250000591 | 250004682 | 1.75 | 58.4 | Neo-adjuvant (N) | 2017-09-29 | 2017-10-13 | null | 02 | N | FLUOROURACIL | 101647634 |
| 250000594 | 250004683 | 1.73 | 91 | null | 2019-11-02 | 2019-11-15 | Carboplatin + Pemetrexed | 02 | null | ATEZOLIZUMAB | 100381831 |
| 250000718 | 250004686 | null | null | null | null | 2019-07-19 | CARBO + FLUOROURACIL | null | null | ENZALUTAMIDE | 100876386 |
| 250000725 | 250004687 | 1.74 | 62.1 | null | 2019-03-22 | 2019-06-18 | Carboplatin+Fluorouracil 4 or 5 day | 02 | null | CARBOPLATIN + VINORELBINE | 101821854 |
| 250000771 | 250004691 | null | null | null | 2019-04-08 | 2019-04-19 | DOXORUBICIN | 02 | N | MITOTANE | 101609837 |
| 250000783 | 250004693 | 1.72 | 81.8 | Palliative (P) | 2018-01-19 | 2018-01-20 | null | 02 | null | CEDIRANIB | 100393154 |
| 250000823 | 250004695 | null | null | Curative (C) | null | 2019-12-05 | Carboplatin AUC 2 - 5 | null | null | CARBOPLATIN + FLUOROURACIL | 100791807 |
| 250000974 | 250004701 | 1.6 | 83 | null | 2019-09-22 | 2019-10-01 | GEMCITABINE + RT | 02 | N | IMATINIB | 101827919 |
| 250001033 | 250004702 | 1.88 | 71.8 | Palliative (P) | null | 2020-08-12 | null | N | N | CAPECITABINE + OXALIPLATIN | 100334733 |
| 250001052 | 250004703 | 1.62 | 50.4 | Palliative (P) | 2020-04-11 | 2020-04-14 | null | N | Y | DOXORUBICIN | 101706684 |
| 250001060 | 250004705 | 1.73 | 63.8 | Curative (C) | 2019-08-10 | 2019-08-11 | CARBOPLATIN + FLUOROURACIL | 02 | null | DOXORUBICIN | 100462361 |
| 250001074 | 250004706 | 1.63 | 102.7 | null | 2017-04-19 | 2017-09-04 | IVADo | 02 | null | CARBOPLATIN + PACLITAXEL | 100864065 |
| 250001092 | 250004708 | 1.72 | 100 | Palliative (P) | null | 2019-11-12 | null | null | N | NB HRNBL-1 CH14.18/CHO ONLY (TRIAL) | 100809939 |
| 250001131 | 250004710 | 1.67 | 72.7 | Curative (C) | 2019-08-13 | 2019-08-14 | Trabectedin | 02 | N | ATEZOLIZUMAB | 100206432 |
| 250001134 | 250004711 | 1.6 | 83 | null | 2018-06-15 | 2018-06-30 | Atezolizumab | N | N | BACILLUS CALMETTE-GUERIN | 100538026 |
| 250001146 | 250004712 | 1.57 | 63.75 | Disease modification (D) | 2019-01-18 | 2019-01-18 | Capecitabine + Cisplatin | 02 | null | IMATINIB | 100099766 |
| 250001203 | 250004714 | null | null | null | 2013-04-07 | 2013-04-07 | CETUXIMAB | 02 | N | DOXORUBICIN + IFOSFAMIDE | 100629010 |
| 250001208 | 250004715 | 1.77 | 75.1 | Palliative (P) | 2019-07-07 | 2019-07-18 | null | 99 | null | DOXORUBICIN | 101544258 |
| 250001268 | 250004718 | 1.56 | 102.2 | Curative (C) | 2017-11-26 | 2018-01-14 | NB HRNBL-1 Isotretinoin | 02 | y | CAPECITABINE + OXALIPLATIN | 100064176 |
| 250001319 | 250004720 | 1.82 | 76.8 | null | 2021-04-09 | 2021-04-15 | Cisplatin + Pemetrexed | 02 | N | CAPECITABINE + OXALIPLATIN | 101740740 |
| 250001320 | 250004721 | null | null | 03 | 2017-05-30 | 2017-06-09 | null | 02 | N | CARBOPLATIN + PEMETREXED | 100015616 |
| 250001584 | 250004731 | null | null | null | 2018-05-23 | 2018-05-25 | null | 01 | null | WT GUIDELINES CYCLOPHOS/DOXORUBICIN | 100910112 |
| 250001607 | 250004734 | 1.6 | 75 | Palliative (P) | null | 2020-03-27 | null | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100796180 |
| 250001610 | 250004735 | 1.76 | 90.9 | Adjuvant (A) | 2020-03-03 | 2020-03-25 | null | 02 | null | EW REL REECUR IFOSFAMIDE | 100857543 |
| 250001643 | 250004737 | 1.64 | 14.6 | Palliative (P) | 2017-07-27 | 2017-08-11 | AVAPRITINIB | 02 | null | CARBOPLATIN + FLUOROURACIL | 101188469 |
| 250001677 | 250004739 | null | 103.7 | Palliative (P) | 2019-11-14 | 2019-12-26 | Trial Unspecified | 02 | Y | TRIAL UNSPECIFIED | 100034115 |